Swiss National Bank - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.9%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$3,313,000
+113.7%
96,174
+3.7%
0.00%
+200.0%
Q2 2020$1,550,000
+46.0%
92,774
+25.9%
0.00%0.0%
Q1 2020$1,062,000
-55.9%
73,674
+2.5%
0.00%
-50.0%
Q4 2019$2,406,000
+65.4%
71,874
+3.5%
0.00%0.0%
Q3 2019$1,455,000
+0.6%
69,4740.0%0.00%0.0%
Q2 2019$1,446,000
-11.8%
69,474
-5.3%
0.00%0.0%
Q1 2019$1,640,000
+2.1%
73,374
+9.2%
0.00%0.0%
Q4 2018$1,607,000
-8.6%
67,174
+4.2%
0.00%0.0%
Q3 2018$1,759,000
+1.4%
64,4740.0%0.00%0.0%
Q2 2018$1,734,000
-15.5%
64,4740.0%0.00%
-33.3%
Q1 2018$2,052,000
+33.7%
64,474
+58.9%
0.00%
+50.0%
Q4 2017$1,535,000
+67.4%
40,574
+9.7%
0.00%
+100.0%
Q3 2017$917,000
+20.7%
36,9740.0%0.00%0.0%
Q2 2017$760,000
-5.4%
36,9740.0%0.00%0.0%
Q1 2017$803,000
+24.7%
36,974
+17.5%
0.00%0.0%
Q4 2016$644,000
+36.4%
31,4740.0%0.00%0.0%
Q3 2016$472,000
+38.4%
31,4740.0%0.00%0.0%
Q2 2016$341,000
+16.8%
31,474
+41.3%
0.00%0.0%
Q1 2016$292,000
+19.2%
22,274
+67.5%
0.00%0.0%
Q4 2015$245,00013,3000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,967,900$42,933,00029.35%
TLP GROUP LLC 2,833,285$30,656,00020.86%
Aisling Capital LLC 2,990,000$32,352,0007.64%
Vivo Capital, LLC 763,009$8,256,0002.26%
RA Capital Management 1,292,940$13,990,0001.94%
Foresite Capital Management III, LLC 235,020$2,543,0001.74%
Palo Alto Investors LP 325,599$3,523,0000.27%
Rock Springs Capital Management LP 293,000$3,170,0000.24%
EMERALD MUTUAL FUND ADVISERS TRUST 332,625$3,599,0000.20%
Virtus ETF Advisers LLC 19,501$211,0000.16%
View complete list of AIMMUNE THERAPEUTICS INC shareholders